Clinical Predictors of Response to Tocilizumab: A Retrospective Multicenter Study

OBJECTIVE: A substantial number of patients with coronavirus disease-2019 (COVID-19) demonstrate severe infection. Cytokine storm is an underlying condition that worsens clinical outcomes. As an interleukin-6 receptor antagonist, tocilizumab is a promising treatment option for COVID-19. This study a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ercan, Selin, Ergan, Begüm, Selin Özuygur, Saliha, Korkmaz, Pervin, Sezai Taşbakan, Mehmet, Basoglu, Özen K., Kerget, Buğra, Akgün, Metin, Elbek, Osman, Sayıner, Abdullah, Kılınç, Oğuz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Thoracic Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450267/
https://www.ncbi.nlm.nih.gov/pubmed/35579229
http://dx.doi.org/10.5152/TurkThoracJ.2022.21179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450267/
https://www.ncbi.nlm.nih.gov/pubmed/35579229
http://dx.doi.org/10.5152/TurkThoracJ.2022.21179

Ejemplares similares